INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹69 Cr | ₹681 Cr | ₹-186 Cr | ₹-141 Cr | ₹-124 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDSWIFT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹69 Cr |
| Mar2024 | ₹681 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-141 Cr |
| Mar2021 | ₹-124 Cr |
How is Cash Flow from Financing Activities of INDSWIFT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹69 Cr | -89.83 | |
| Mar2024 | ₹681 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-141 Cr | Negative | |
| Mar2021 | ₹-124 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,308.9 Cr | 5.8% | 10.5% | 67.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 5.8% |
10.5% |
67.2% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses